L413-0166 Screening compound: N-[(3-ethoxy-4-methoxyphenyl)methyl]-4-(1-propanoyl-2,3-dihydro-1H-indol-5-yl)benzamide

L413-0166 Screening compound: N-[(3-ethoxy-4-methoxyphenyl)methyl]-4-(1-propanoyl-2,3-dihydro-1H-indol-5-yl)benzamide
L413-0166 Screening compound: N-[(3-ethoxy-4-methoxyphenyl)methyl]-4-(1-propanoyl-2,3-dihydro-1H-indol-5-yl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L413-0166
N-[(3-ethoxy-4-methoxyphenyl)methyl]-4-(1-propanoyl-2,3-dihydro-1H-indol-5-yl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L413-0166

Molecular Formula

C28H30N2O4 (C28 H30 N2 O4)

Compound Name

N-[(3-ethoxy-4-methoxyphenyl)methyl]-4-(1-propanoyl-2,3-dihydro-1H-indol-5-yl)benzamide

IUPAC name

N-[(3-ethoxy-4-methoxyphenyl)methyl]-4-(1-propanoyl-23-dihydro-1H-indol-5-yl)benzamide

SMILES

CCC(N(CC1)c(cc2)c1cc2-c(cc1)ccc1C(NCc(cc1)cc(OCC)c1OC)=O)=O

InChI

InChI=1S/C28H30N2O4/c1-4-27(31)30-15-14-23-17-22(11-12-24(23)30)20-7-9-21(10-8-20)28(32)29-18-19-6-13-25(33-3)26(16-19)34-5-2/h6-13,16-17H,4-5,14-15,18H2,1-3H3,(H,29,32)

InChI Key

FIRUCVGGXGMPIC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27251431

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

458.56

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.332

Distribution Coefficient, logD

4.332

Water Solubility, LogSw

-4.31

Polar Surface Area

54.644

Acid Dissociation Constant (pKa)

13.29

Base Dissociation Constant (pKb)

-0.59

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

L413-0166 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Bromodomain Modulators Library (5801 compounds)

Lipid Metabolism Library (9174 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cardiovascular
  • Metabolic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Cancer
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Structure:
  • Mimetics
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with L413-0166 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L413-0166?
Check Price and Availability of L413-0166, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L413-0166 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L413-0166
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L413-0166
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L413-0166 available by request